Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 12, 2012
Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14Ingrid U Scott, Paul C Vanveldhuisen, Neal L Oden, et al.
JAMA Ophthalmology|May 12, 2017
Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4Ingrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2011
Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED)Michael P Bogenschutz, Dennis M Donovan, Bryon Adinoff, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 15, 2010
Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9Barbara A Blodi, Amitha Domalpally, Ingrid U Scott, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 16, 2009
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6Ingrid U Scott, Michael S Ip, Paul C VanVeldhuisen, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 16, 2009
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5Michael S Ip, Ingrid U Scott, Paul C VanVeldhuisen, et al.
JAMA|May 12, 2017
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical TrialIngrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.
Translational Vision Science & Technology|June 27, 2023
High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21Nitish Mehta, Sachi Patil, Vikram Modi, et al.
Addiction (Abingdon, England)|January 7, 2017
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trialPhilip T Korthuis, Paula J Lum, Pamela Vergara-Rodriguez, et al.
JAMA Internal Medicine|September 3, 2014
Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trialMichael P Bogenschutz, Dennis M Donovan, Raul N Mandler, et al.
Pageof 9